RecruitingPHASE1, PHASE2NCT07017946
Intestinal Microbiome Transplant in ALS
Studying Amyotrophic Lateral Sclerosis (ALS)
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Duke University
- Principal Investigator
- Richard Bedlack, MD, PhDDuke University
- Intervention
- MTP-101C(drug)
- Enrollment
- 20 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2026 – 2026
Study locations (1)
- Duke University Medical Center, Durham, North Carolina, United States
Collaborators
University of Minnesota
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07017946 on ClinicalTrials.govOther trials for Amyotrophic Lateral Sclerosis (ALS)
Additional recruiting or active studies for the same condition.
- ENROLLING BY INVITATIONNANCT07539662Unrelated Umbilical Cord Blood Transplantation for the Treatment of Amyotrophic Lateral Sclerosis (ALS)Institute of Hematology & Blood Diseases Hospital, China
- RECRUITINGPHASE1, PHASE2NCT07287397Study is to Assess the Safety and Tolerability of VTx-002 in Participants With ALSVector Y Therapeutics
- ACTIVE NOT RECRUITINGPHASE2NCT07023835Usnoflast Neuromuscular Investigation for Treatment Efficacy in Amyotrophic Lateral SclerosisZydus Therapeutics Inc.
- RECRUITINGNANCT07413718Inspiratory Muscle Training in Amiotrophyc Lateral SclerosisUniversity Ramon Llull
- RECRUITINGPHASE1NCT06665165AMX0114 in Adult Participants With Amyotrophic Lateral SclerosisAmylyx Pharmaceuticals Inc.
- RECRUITINGNANCT06609213Oral Intake of Enteral Nutrition Formula Preceding Placement and Feeding Via GTube and Its Impact on Formula Intolerance in pALSAndrea Charvet
- RECRUITINGNANCT06249412The Importance of Positive Expiratory Pressure Associated With the In-exsufflator in ALS PatientsGroupe Hospitalier du Havre
- RECRUITINGNANCT06834269Transcranial Static Magnetic Stimulation (tSMS) and Potential Theranostic Biomarkers in Amyotrophic Lateral Sclerosis.Campus Bio-Medico University